Pharmarise Holdings (TSE:2796) YoY EBITDA Growth : -73.87% (As of Feb. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Pharmarise Holdings YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Pharmarise Holdings's YoY EBITDA Growth for the quarter that ended in Feb. 2024 was -73.87%.

Pharmarise Holdings's EBITDA per Share for the three months ended in Feb. 2024 was 円9.42.

Pharmarise Holdings YoY EBITDA Growth Historical Data

The historical data trend for Pharmarise Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmarise Holdings YoY EBITDA Growth Chart

Pharmarise Holdings Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

YoY EBITDA Growth

Get a 7-Day Free Trial

-18.69

35.11

25.55

2.54

-14.26

Pharmarise Holdings Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
YoY EBITDA Growth	Get a 7-Day Free Trial															63.77	-8.53	-2.87	225.65	-73.87

Pharmarise Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Pharmarise Holdings's YoY EBITDA Growth for the fiscal year that ended in May. 2023 is calculated as:

	YoY EBITDA Growth (A: May. 2023 )
=	(EBITDA per Share (A: May. 2023 )	-	EBITDA per Share (A: May. 2022 ))	/	\| EBITDA per Share (A: May. 2022 ) \|
=	(247.633	-	288.822)	/	\| 288.822 \|
=	-14.26 %

Pharmarise Holdings's YoY EBITDA Growth for the quarter that ended in Feb. 2024 is calculated as:

	YoY EBITDA Growth (Q: Feb. 2024 )
=	(EBITDA per Share (Q: Feb. 2024 )	-	EBITDA per Share (Q: Feb. 2023 ))	/	\| EBITDA per Share (Q: Feb. 2023 )) \|
=	(9.424	-	36.07)	/	\| 36.07 \|
=	-73.87 %

Pharmarise Holdings YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmarise Holdings (TSE:2796) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011

Website

http://www.pharmarise.com

Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.

Pharmarise Holdings (TSE:2796) Headlines

No Headlines